olmesartan has been researched along with meperidine in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (meperidine) | Trials (meperidine) | Recent Studies (post-2010) (meperidine) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 5,748 | 1,228 | 343 |
| Protein | Taxonomy | olmesartan (IC50) | meperidine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.5 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.5 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.4075 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.5 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 1.435 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.5 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.5 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.3236 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for olmesartan and meperidine
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |